US 8962824
Composition of novel carbohydrate drug for treatment of human diseases
granted A61KA61K31/70A61K31/715
Quick answer
US patent 8962824 (Composition of novel carbohydrate drug for treatment of human diseases) held by GALECTIN THERAPEUTICS, INC. expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GALECTIN THERAPEUTICS, INC.
- Grant date
- Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/70, A61K31/715, A61K31/738, A61K45/06